Integrated Brain & Body Care in Wesley Chapel, Florida
You react to things most people tolerate without a second thought. Foods, smells, medications, temperature changes, stress, and supplements that should help do not always go the way you planned. Sometimes you know what you will react to. Other times you tolerate something fine one day and cannot the next. The unpredictability is its own kind of exhausting.
You have fought for specialty referrals. You have seen allergists and immunologists. You have been trialed on different medications. And despite seeing more specialists, the recommendations rarely change. You get a few tools to manage reactions and you are sent on your way.
But here is what nobody is addressing. When your MCAS flares, your heart rate goes through the roof, you are lightheaded, and your gut is a mess. Everything else falls apart at the same time. And when you ask any provider who is not directly treating your MCAS how it is affecting your other symptoms, nobody wants to have that conversation. Everyone is focused on their own piece. Nobody is looking at how it all connects.
That is not a coincidence and it is not in your head. Your nervous system, your immune system, and your gut are failing to regulate together. That is exactly what we evaluate.
If any of this sounds familiar, you are in the right place:
When your MCAS flares, your already limited baseline gets significantly worse. That is not a coincidence. Nothing about this condition operates in isolation, and treating it that way has never been enough.
Most of our MCAS patients have been managing reactions for years, often decades, without anyone looking at what is driving the hyperreactivity in the first place.
Mast cell activation syndrome is still a relatively new diagnosis in mainstream medicine. Most providers do not have meaningful training on it, which is a big part of why you keep hitting walls. And while there are labs that can be run, including tryptase which should always be checked, the labs are not perfect. A normal tryptase does not mean you do not have MCAS. It means the current testing has limits. And that means someone has to be willing to go beyond what standard labs can tell you to actually understand what is driving your mast cell and histamine responses.
That is where we start.
Markers like iron, ferritin, B vitamins, thyroid function, blood sugar regulation, hormones, and inflammatory proteins including C-reactive protein all influence immune function and mast cell behavior. These are not markers that show up on a standard allergy workup. But they consistently show up as significant factors when we look at the full picture. Mast cells are sensitive to metabolic stress. When key nutrients are off, hormones are dysregulated, or inflammatory markers are elevated, mast cell thresholds drop and less is required to trigger a reaction.
Your gut is home to a significant portion of your body’s mast cells and is one of the primary drivers of mast cell reactivity. Stool testing, food sensitivity testing, and gut lining assessment are not run on everyone. They are run when the history and pattern point toward the gut as a significant driver. When it is, these tests frequently reveal bacterial imbalances, inflammatory markers, and immune activation that standard allergy panels completely miss. Addressing the gut environment in the right patient produces meaningful reductions in mast cell reactivity because you are addressing what is driving the response, not just suppressing it.
When the nervous system is dysregulated, it drives systemic inflammation. That inflammation exaggerates mast cell responses. And as mast cell activity increases, it worsens the nervous system dysregulation and everything connected to it. This is why your MCAS does not improve when everything else is ignored. The nervous system and the immune system are constantly talking to each other, and both have to be addressed.
For some patients, mold, biotoxin illness, or chronic infections are contributing to why the immune system stays in a reactive state. This is not the first place we look, and it is not something every MCAS patient needs to go down. But when the history and pattern point toward it, it becomes part of the picture we evaluate. Getting the metabolic and neurological pieces right first is what allows us to determine whether this layer needs to be addressed at all.
We do not treat MCAS through the lens of allergy alone. We evaluate the full system driving it.
Beyond standard mast cell markers including tryptase, we look at iron and ferritin status, thyroid and metabolic markers, hormonal patterns, blood sugar regulation, inflammatory markers including C-reactive protein, and gut health when the history points toward it. When indicated, we also evaluate for mold, biotoxin exposure, and chronic infections. This is not a standard allergy workup. It is an investigation into what is making your immune system behave the way it is. The data points us in the direction of where we need to go, and we follow it rather than applying the same protocol to everyone.
We assess how your autonomic nervous system is functioning and how your brain’s regulatory systems are contributing to immune dysregulation. Advanced oculomotor and vestibular testing provides objective data on how your nervous system is processing and regulating, information that standard evaluations do not capture.
Treatment is built around what your data actually shows. For some patients, addressing the metabolic picture produces the most significant reduction in mast cell reactivity. For others, restoring neurological and autonomic regulation is the primary lever. Most of the time it is both, addressed together because that is how your biology actually works. We treat the co-diagnoses that travel with MCAS at the same time, because treating MCAS while ignoring POTS or EDS means the system never fully stabilizes.
Your care plan is determined entirely by your evaluation results. Most patients follow one of three paths:
Neurology-Focused Path
Best when symptoms are driven primarily by:
Functional Medicine-Focused Path
Best when symptoms are driven mainly by:
Combined Brain-Body Path (most common)
Most MCAS patients benefit from a coordinated approach combining:
We pace care carefully around your reactivity patterns and symptom threshold to minimize flares. Medications and supplements are reviewed to ensure they are appropriate, necessary, and not contributing to mast cell burden. If needed, we co-manage or triage red flags including:
Yes. A normal tryptase does not rule out MCAS. Tryptase is one marker and it is not always elevated even in confirmed cases. MCAS is a clinical diagnosis supported by symptoms, history, and response to treatment. If your tryptase was normal but your symptoms match, that does not mean you do not have it. It means the evaluation needs to go further.
Because MCAS does not operate in isolation. When mast cells degranulate, the chemical mediators they release destabilize autonomic regulation, drive systemic inflammation, and place a direct burden on your nervous system. If you also have POTS, dysautonomia, or ME/CFS, those systems are directly affected by mast cell activity. This is why a flare rarely stays contained to one area.
Because those medications address the reaction, not what is driving it. If the underlying metabolic dysfunction, gut dysbiosis, neurological dysregulation, or immune burden that is making your mast cells hyperreactive is never addressed, the threshold for triggering reactions stays low regardless of what you take to suppress them. Managing the output without identifying the input is why so many MCAS patients plateau.
Diet can reduce the load on an already reactive system, but it is rarely sufficient on its own and it does not address what is making the mast cells hyperreactive in the first place. A low histamine diet may reduce symptoms temporarily. It does not fix the gut environment, the metabolic picture, or the neurological dysregulation driving reactivity. We evaluate those drivers directly rather than relying on dietary restriction as a primary strategy.
Yes. The mediators released during mast cell activation directly affect the nervous system, blood vessel tone, and brain function. Brain fog, cognitive fatigue, dizziness, and autonomic instability are all consistent with MCAS, particularly when it co-occurs with POTS or dysautonomia. Treating the neurological component is not separate from treating MCAS. It is part of it.
No. We see patients from across the country through our out-of-state intensive program. Because MCAS almost always co-occurs with other conditions like POTS, EDS, or ME/CFS, the intensive format allows us to evaluate and address the full picture in a concentrated period of time rather than managing one piece at a time over months of appointments.
We do not treat MCAS through the lens of allergy alone. We evaluate the metabolic picture, gut health, hormonal patterns, neurological function, and immune burden together because that is what is actually driving mast cell hyperreactivity in most patients. We also treat the co-diagnoses that travel with MCAS simultaneously. If you have POTS, EDS, or ME/CFS alongside your MCAS, all of it gets addressed as part of one integrated plan.
Step 1 — Complimentary Intake Call
A conversation with our patient coordinator to learn about your history, answer your questions, and determine whether we are the right fit.
Step 2 — Provider Consultation
A clinical conversation with Dr. Zimmerman. You will complete intake paperwork beforehand so this is a real clinical conversation from the start, not an introduction. A fee is charged for this visit and is applied toward your care if you move forward.
Step 3 — Precision Evaluation
Targeted neurological, autonomic, and functional medicine testing to identify exactly what is driving your MCAS and what else is contributing.
Step 4 — Report of Findings
A clear, specific plan built around your data. Not a protocol. A plan built from your case from the beginning because MCAS rarely has a single driver.
If MCAS has left you managing reactions instead of getting your life back, and no one has looked at the full picture of what is driving it, that changes here. Call 813-838-4005 or start the process online to see if we are the right fit.
Bauer ME, Teixeira AL. Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation. Annals of Allergy, Asthma and Immunology. 2023;132(4):440-448. doi:10.1016/j.anai.2023.10.032
Blitshteyn S. Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities. Current Neurology and Neuroscience Reports. 2023;23(11):769-776. doi:10.1007/s11910-023-01307-w
Castells M, Giannetti M, Hamilton M, et al. Mast cell activation syndrome: Current understanding and research needs. Journal of Allergy and Clinical Immunology. 2024;154:255-263.
Weinstock LB, Nelson RM, Blitshteyn S. Neuropsychiatric manifestations of mast cell activation syndrome and response to mast-cell-directed treatment: A case series. Journal of Personalized Medicine. 2023;13(11):1562. doi:10.3390/jpm13111562
You may also want to read about POTS and Dysautonomia, Ehlers-Danlos Syndrome, ME/CFS, Long COVID, Functional Medicine, and Lab Testing, since these conditions and evaluation tools directly overlap with MCAS and are almost always part of the full picture we evaluate and treat together.
Medically Reviewed by: Spencer Zimmerman, FNP-C, DC, DACNB
Last Updated: June 28, 2026
At our dedicated doctor’s office, we take immense pride in the care and service we provide to our patients. Here, you can discover the genuine experiences and heartfelt feedback from those who have entrusted us with their health and well-being. These testimonials offer valuable insights into the compassionate and expert care that defines our practice. We are grateful for the trust our patients place in us and invite you to explore their stories, which reflect the exceptional standard of healthcare we aim to deliver every day.
Finally unravel the mysteries of your brain health issues so you can pave the way to lasting clarity and well-being by scheduling a time to speak with our team.